Blog
RSS FeedPosted by Michael Wonder on 10 Dec 2020
Ontario to begin vaccinations next week in Toronto, Ottawa
10 December 2020 - The first vaccines will go to health care workers at long-term care homes and other high-risk ...
Posted by Michael Wonder on 10 Dec 2020
Australian COVID vaccine terminated due to HIV ‘false positives’
11 December 2020 - A billion-dollar deal for the Morrison government to buy more than 50 million doses of the ...
Posted by Michael Wonder on 10 Dec 2020
X4 Pharmaceuticals receives rare paediatric disease designation from FDA for mavorixafor for the treatment of WHIM syndrome
10 December 2020 - X4 Pharmaceuticals today announced that it has received rare paediatric disease designation from the U.S. FDA ...
Posted by Michael Wonder on 10 Dec 2020
Switzerland ramps up COVID-19 vaccine order
9 December 2020 - Switzerland has increased its coronavirus vaccine order with Moderna by three million doses. ...
Posted by Michael Wonder on 10 Dec 2020
Lantheus Holdings announces acceptance and priority review of new drug application for PyLTM (18F DCFPyL), a PSMA targeted prostate cancer PET imaging agent
9 December 2020 - PDUFA action date of 28 May 2021 assigned by U.S. FDA. ...
Posted by Michael Wonder on 10 Dec 2020
FDA accepts GSK’s filing of Nucala (mepolizumab) for use in chronic rhinosinusitis with nasal polyps
8 December 2020 - If approved, Nucala would be the only treatment approved in the US for use in four eosinophil-driven ...
Posted by Michael Wonder on 10 Dec 2020
Hackers steal Pfizer/BioNTech COVID-19 vaccine data in Europe, companies say
10 December 2020 - U.S. drug maker Pfizer and its German partner BioNTech said on Wednesday that documents related to development ...
Posted by Michael Wonder on 10 Dec 2020
Valeo Pharma announces Health Canada approval for Redesca and Redesca Hp
9 December 2020 - Valeo Pharma announced today that Health Canada has issued a Notice of Compliance for Redesca and ...
Posted by Michael Wonder on 09 Dec 2020
ReGelTec receives FDA breakthrough designation for its Hydrafil system
9 December 2020 - ReGelTec announced today that it has received breakthrough device designation from the Center for Devices and Radiological ...
Posted by Michael Wonder on 09 Dec 2020
Amgen's sotorasib granted breakthrough therapy designation for advanced or metastatic non-small cell lung cancer patients with KRAS G12C mutation
8 December 2020 - Sotorasib also accepted into FDA's Real-Time Oncology Review pilot program. ...
Posted by Michael Wonder on 09 Dec 2020
Canada health regulator approves Pfizer's COVID-19 vaccine
10 December 2020 - Canada’s health regulator has approved Pfizer’s COVID-19 vaccine. ...
Posted by Michael Wonder on 09 Dec 2020
COVID-19 vaccine trial deaths were not related to treatment: Pfizer
9 December 2020 - Two people who received Pfizer’s experimental COVID-19 vaccine died during clinical trials, but the pharma giant says ...
Posted by Michael Wonder on 09 Dec 2020
Blunders eroded U.S. confidence in early vaccine front-runner
8 December 2020 - The Oxford-AstraZeneca effort held great promise to help arrest the pandemic. But a series of miscues caused ...
Posted by Michael Wonder on 09 Dec 2020
Albireo submits for U.S. FDA and EMA product approval of once daily odevixibat for PFIC
8 December 2020 - Data on PFIC types 1, 2, 3 submitted to support use across a wide range of patients. ...
Posted by Michael Wonder on 09 Dec 2020
US FDA accepts for priority review the biologics license application for Pfizer’s investigational 20 valent pneumococcal conjugate vaccine for adults 18 years of age and older
8 December 2020 - If approved, the vaccine will help protect adults against 20 serotypes responsible for the majority of invasive ...